Ralf Fang
About Ralf Fang
Ralf Fang serves as the Director of Patents at Structure Therapeutics, a position he has held since 2022. He has extensive experience in patent law, having previously worked at Global Blood Therapeutics and Morgan, Lewis & Bockius LLP.
Work at Structure Therapeutics
Ralf Fang serves as the Director of Patents at Structure Therapeutics, a position he has held since 2022. In this role, he is responsible for overseeing patent strategies and managing intellectual property matters. His work supports the company's mission to advance therapeutic solutions. Structure Therapeutics operates within the biotechnology sector, focusing on innovative treatments.
Previous Experience at Global Blood Therapeutics
Prior to his current role, Ralf Fang worked at Global Blood Therapeutics for a total of six years. He began as a Patent Agent from 2016 to 2018, where he contributed to the development and management of patent portfolios. He then advanced to the position of Senior Patent Agent from 2018 to 2022, further enhancing his expertise in patent law and strategy within the biotechnology field.
Experience at Morgan, Lewis & Bockius LLP
Ralf Fang's earlier career includes eight years as a Patent Agent at Morgan, Lewis & Bockius LLP from 2008 to 2016. During his tenure, he gained substantial experience in patent prosecution and litigation support. His work involved collaborating with clients to protect their intellectual property rights, focusing on various technology sectors.
Education and Expertise
Ralf Fang studied at Europa Fachhochschule Fresenius in Idstein, where he earned a Dipl.-Ing. (FH) in Chemistry from 1996 to 2000. His educational background provides a strong foundation in scientific principles, which supports his work in patent law and intellectual property management in the biotechnology industry.